BAJAJ HEALTHCARE share price has zoomed 6% and is presently trading at Rs 400.9.
Meanwhile, the BSE HEALTHCARE index is at 41,030.5 (down 0.1%).
Among the top gainers in the BSE HEALTHCARE index today are SUVEN PHARMACEUTICALS (up 5.0%) and CAPLIN POINT (up 3.5%).
Cadila Healthcare (down 3.0%) and APOLLO HOSPITALS (down 2.1%) are among the top losers today.
Over the last one year, BAJAJ HEALTHCARE has moved up from Rs 361.7 to Rs 400.9, registering a gain of Rs 39.3 (up 10.9%).
On the other hand, the BSE HEALTHCARE index has moved up from 28,343.8 to 41,030.5, registering a gain of 44.8% during the last 12 months.
The top gainers among the BSE HEALTHCARE index stocks during this same period were Jubilant Pharmova (up 119.8%), SUVEN PHARMACEUTICALS (up 108.8%) and GSK Pharma (up 107.8%).
Must See: These Segments are Witnessing Incredible Growth with Modi's Push
The BSE Sensex is at 79,814.6 (up 0.1%).
The top gainers among the BSE Sensex today are JSW Steel (up 1.9%) and HDFC Bank (up 1.3%). The most traded stocks in the BSE Sensex are Tata Steel and SBI.
In the meantime, NSE Nifty is at 24,381.5 (up 0.1%). JSW Steel and Axis Bank are among the top gainers in NSE NIFTY.
Over the last 12 months, the BSE Sensex has moved up from 65,846.5 to 79,814.6, registering a gain of 13,968.1 points (up 21.2%).
BAJAJ HEALTHCARE net profit fell 386.9% YoY to Rs -320 million for the quarter ended March 2024, compared to a profit of Rs 112 million a year ago. Net sales declined 13.1% to Rs 1,339 million during the period as against Rs 1,541 million in January-March 2023.
For the year ended March 2023, BAJAJ HEALTHCARE reported 39.7% decrease in net profit to Rs 430 million compared to net profit of Rs 714 million during FY22. Revenue of the company fell 1.0% to Rs 6,733 million during FY23.
The current Price to earnings ratio of BAJAJ HEALTHCARE, based on rolling 12 month earnings, stands at -77.2.
Equitymaster requests your view! Post a comment on "BAJAJ HEALTHCARE Gains 6%; BSE HEALTHCARE Index Down 0.1%". Click here!
Comments are moderated by Equitymaster, in accordance with the Terms of Use, and may not appear
on this article until they have been reviewed and deemed appropriate for posting.
In the meantime, you may want to share this article with your friends!